Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
Titel:
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
Auteur:
Ozen, Ahmet Chongsrisawat, Voranush Sefer, Asena Pinar Kolukisa, Burcu Jalbert, Jessica J Meagher, Karoline A Brackin, Taylor Feldman, Hagit Baris Baris, Safa Karakoc-Aydiner, Elif Ergelen, Rabia Fuss, Ivan J Moorman, Heather Suratannon, Narissara Suphapeetiporn, Kanya Perlee, Lorah Harari, Olivier A Yancopoulos, George D Lenardo, Michael J